Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1757)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (14)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4175)
  2. Weinberg Fellows (2758)
  3. Hematologic Malignancies, Division of (2493)
  4. Solid Tumor Oncology Division (2424)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (346)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4494)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A bioinformatics framework for high-sensitivity detection and monitoring of oncogenic gene fusions in plasma cfDNA
    Meeting Abstract

    Patel, J.; Hasan, M.; Meng, F.; Jing, X.; Tam, G.; Johnson, I.; Zheng, Y.; Bandlamudi, C.; Stewart, C.; Won, H.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Meeting Abstract

    Li, Q.; Razavi, P.; Li, Z.; Da Cruz Paula, A. F.; Brogi, E.; Scaltriti, M.; Reis, J. S.; Chandarlapaty, S.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • TP53-stabilization with APR-246 enhances antitumor effects of immune checkpoint in preclinical models
    Meeting Abstract

    Ghosh, A.; Michel, J.; Dong, L.; Suek, N.; Zhong, H.; Budhu, S.; de Henau, O.; Wolchok, J.; Merghoub, T.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Meeting Abstract

    Shrestha Bhattarai, T.; Shamu, T.; Patel, S.; Gorelick, A.; Chang, M. T.; Gavrila, E. I.; Gao, J. J.; Donoghue, M. T.; Gao, P. S.; Soumerai, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase II clinical trial of leuprolide for enhancement of immune reconstitution after ex vivo CD34+ cell-selected allogeneic HCT with TBI-based conditioning
    Meeting Abstract

    Cho, C.; Devlin, S. M.; Avecilla, S. T.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Maloy, M.; Maslak, P.; O'Reilly, R. J.; Papadopoulos, E. B.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR)-mediated BCL11B suppression in lymphoid progenitor cells propagates natural killer-like cell development
    Meeting Abstract

    Maluski, M.; Ghosh, A.; Herbst, J.; Scholl, V.; Baumann, R.; Geffers, R.; Meyer, J.; Krueger, A.; Schambach, A.; van den Brink, M.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • EASIX score predicts high-grade acute GVHD, non-relapse mortality, and overall survival in adult patients undergoing unmodified or CD34-selected allogeneic HCT
    Meeting Abstract

    Sanchez-Escamilla, M.; Hilden, P.; Malloy, M.; Ruiz, J. D.; Fatmi, S.; Sauter, C. S.; Ponce, D.; Giralt, S. A.; Scordo, M.; Perales, M. A.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Altered nuclear export signal recognition as a driver of oncogenesis
    Journal Article

    Taylor, J.; Sendino, M.; Gorelick, A. N.; Pastore, A.; Chang, M. T.; Penson, A. V.; Gavrila, E. I.; Stewart, C.; Melnik, E. M.; Herrejon Chavez, F.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Systemic therapy for metastatic renal cell carcinoma-is timing everything?
    Editorial

    Kotecha, R. R.; Voss, M. H.
    Annals of Translational Medicine (2019)

    Fulltext@MSK | Save
  • Clinicopathologic features associated with survival after cytoreductive nephrectomy for nonclear cell renal cell carcinoma
    Journal Article

    Silagy, A. W.; Flynn, J.; Mano, R.; Blum, K. A.; Marcon, J.; DiNatale, R. G.; Sanchez, A.; Carlo, M. I.; Motzer, R. J.; Coleman, J. A.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save